A score system to predict noreflow in primary percutaneous coronary intervention: The PIANO Score

C Dai, M Liu, Y Zhou, D Lu, C Li… - European Journal of …, 2022 - Wiley Online Library
no-reflow. Therefore, the aim of this study was to establish and validate a user-friendly
score system for angiographic no-reflow in patients with STEMI undergoing primary PCI. …

Clinical and Laboratory Predictors of No-reflow during Primary Percutaneous Coronary Intervention

H Mansour, A Elabd, MA Ghazy, W Sameer… - The Egyptian Journal …, 2021 - journals.ekb.eg
… of no-reflow phenomenon in … the prevention and treatment of no-reflow phenomenon. Hence,
it is important to define new indicators for each pathophysiological mechanism of no-reflow (…

The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction

HA Barman, S Kahyaoglu, E Durmaz, A Atici… - Coronary artery …, 2020 - journals.lww.com
… TIA were independent risk factors for no-reflow. We found the TIMI thrombus grade to be
higher in patients with no-reflow. In conclusion, the no-reflow phenomenon remains a significant …

Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion: A clinical study

A Schiphorst, S Charron, WB Hassen… - Journal of Cerebral …, 2021 - journals.sagepub.com
… In the present proof-of-principle study, we therefore aimed to assess the incidence of no-reflow
Based on available pre-clinical, particularly non-human primate, literature, no-reflow was …

Mechanisms of the “no-reflow” phenomenon after acute myocardial infarction: Potential role of pericytes

S Kaul, C Methner, Z Cao, A Mishra - Basic to Translational Science, 2023 - jacc.org
… and no reflow. Reversing pericyte contraction pharmacologically reduces no reflow and …
The iatrogenic causes of no reflow and their treatment are beyond the scope of this review. …

[HTML][HTML] Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary …

HM Badran, AA Fatah, G Soltan - Journal of Clinical and …, 2020 - ncbi.nlm.nih.gov
… In the present study, PLR was an independent predictor of no-reflow in STEMI patients
treated with PPCI. PLR was directly correlated to cardiac enzyme level (CK-MB) and showed …

[HTML][HTML] Angiographic coronary no-reflow after primary percutaneous coronary intervention–a combination of an insensitive diagnostic method, inappropriate timing …

G Ndrepepa - EuroIntervention, 2023 - eurointervention.pcronline.com
… Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-… So
far, no therapy has produced a consistent clinical benefit by preventing or reversing CNR after …

[HTML][HTML] Protective effect of Danhong injection in patients with acute myocardial infarction at a high risk of no-reflow during primary percutaneous coronary intervention

Q You, J Wang, W Dong, F Tian, HX Liu… - Journal of Geriatric …, 2019 - ncbi.nlm.nih.gov
… There was no significant difference in the infarct-related artery and incidence of no reflow
in coronary angiography between the two groups after PCI (P > 0.05 for all). Hence, the two …

Efficacy of sodium nitroprusside combined with verapamil in the treatment of no-reflow during coronary interventional therapy

C Gao, L Wang, L Li, P Shao, F Li, C Kang… - Cardiology Plus, 2019 - journals.lww.com
… , etc., Moreover, no-reflow remarkably increases the risks of … that are available to prevent
and treatno-reflow” of coronary … was used to treat patients with no-reflow of coronary arteries …

Predictors of No-reflow Phenomenon Development in Patients Presenting with ST Segment Elevated Myocardial Infarction and Treated with Primary Percutaneous …

E Donmez, S Ozcan, I Sahin, E Okuyan - Bagcilar Medical Bulletin, 2023 - go.gale.com
… Predictive factors for no-reflow phenomenon have not been clearly defined. We … for no-reflow
development in patients who presented with ST-segment elevation MI (STEMI) and treated